[Effect of pyrimidine derivatives on the phagocytic ability of the reticuloendothelial system and effectiveness of levomycetin therapy of experimental infection].
D000818:Animals; D002701:Chloramphenicol / Q000008:administration & dosage*; D003864:Depression, Chemical; D004357:Drug Synergism; D008099:Liver / Q000187:drug effects; D008297:Male; D051379:Mice; D012157:Mononuclear Phagocyte System / Q000187:drug effects*; D010587:Phagocytosis / Q000187:drug effects*; D010759:Phosphorus Isotopes; D011743:Pyrimidines / Q000494:pharmacology*; D012480:Salmonella Infections / Q000188:drug therapy* / Q000401:mortality; D013154:Spleen / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000401:mortality; D013210:Staphylococcus; D013268:Stimulation, Chemical; D014498:Uracil / Q000008:administration & dosage*
D010759:Phosphorus Isotopes; D011743:Pyrimidines; D014498:Uracil; D002701:Chloramphenicol
Vliianie proizvodnykh pirimidina na fagotsitarnuiu sposobnost' retimulo-endotelial'noĭ sistemy i effektivnost' lecheniia levomitsetinom éksperimental'nykh infektsiĭ.